Oxford Nanopore Technologies’ (ONT) “Outperform” Rating Reiterated at Royal Bank Of Canada

Oxford Nanopore Technologies (LON:ONT)‘s stock had its “outperform” rating reissued by analysts at Royal Bank Of Canada in a note issued to investors on Tuesday,London Stock Exchange reports. They presently have a GBX 225 price objective on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 74.42% from the stock’s current price.

Oxford Nanopore Technologies Trading Down 0.7%

Shares of LON ONT opened at GBX 129 on Tuesday. The stock has a market cap of £1.25 billion, a price-to-earnings ratio of -8.54 and a beta of 0.87. The business has a 50 day simple moving average of GBX 117.33 and a 200 day simple moving average of GBX 129.61. Oxford Nanopore Technologies has a 52 week low of GBX 104 and a 52 week high of GBX 224.80. The company has a debt-to-equity ratio of 8.96, a quick ratio of 6.01 and a current ratio of 3.56.

Oxford Nanopore Technologies (LON:ONT) last announced its quarterly earnings results on Monday, March 2nd. The company reported GBX (15.10) EPS for the quarter. Oxford Nanopore Technologies had a negative net margin of 64.85% and a negative return on equity of 29.43%.

Insider Activity at Oxford Nanopore Technologies

In other news, insider Nick Keher purchased 22,018 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was acquired at an average price of GBX 113 per share, with a total value of £24,880.34. Over the last three months, insiders purchased 22,678 shares of company stock valued at $2,563,129. Insiders own 2.33% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.